About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Phase IIA Study in Patients With Schizophrenia

Phase IIA Study in Patients With Schizophrenia

NCT00686998·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

AstraZeneca

Age

18–65

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Females of non-childbearing potential
Diagnosis of Schizophrenia

You may not be if

Clinically relevant disease and /or abnormalities.
Alcohol or substance abuse not in remission
Enrollment in another investigational study within 30 days

The record

StatusCompleted

PhasePhase 2

Taking part106

StartedMay 2008

UpdatedMar 29, 2013

Conditions

Where1

Research Site
Rockville, Maryland, United States